Search Results - "Hodis, H N"

Long-term soy isoflavone supplementation and cognition in women: A randomized, controlled trial by HENDERSON, V. W, ST. JOHN, J. A, HODIS, H. N, KONO, N, MCCLEARY, C. A, FRANKE, A. A, MACK, W. J

“…To determine the cognitive effects of long-term dietary soy isoflavones in a daily dose comparable to that of traditional Asian diets. In the double-blind…”
Get full text

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong by Langer, R. D., Simon, J. A., Pines, A., Lobo, R. A., Hodis, H. N., Pickar, J. H., Archer, D. F., Sarrel, P. M., Utian, W. H.

“…The US Preventive Services Task Force (USPSTF) Draft Recommendation statement on Menopausal Hormone Therapy: Primary Prevention for Chronic Diseases, released…”
Get full text

Using Basic Science to Design a Clinical Trial: Baseline Characteristics of Women Enrolled in the Kronos Early Estrogen Prevention Study (KEEPS) by Miller, V. M., Black, D. M., Brinton, E. A., Budoff, M. J., Cedars, M. I., Hodis, H. N., Lobo, R. A., Manson, J. E., Merriam, G. R., Naftolin, F., Santoro, N., Taylor, H. S., Harman, S. M.

“…Observational and epidemiological studies suggest that menopausal hormone therapy (MHT) reduces cardiovascular disease (CVD) risk. However, results from…”
Get full text

Estrogen in the prevention of atherosclerosis: A Randomized, double-blind, placebo-controlled trial by HODIS, Howard N, MACK, Wendy J, LOBO, Roger A, SHOUPE, Donna, SEVANIAN, Alex, MAHRER, Peter R, SELZER, Robert H, LIU, Chao-Ran, LIU, Ci-Hua, AZEN, Stanley P

“…Although observational studies suggest that estrogen replacement therapy (ERT) reduces cardiovascular morbidity and mortality in postmenopausal women, use of…”
Get full text

Hormone replacement therapy - where are we now? by Langer, R. D., Hodis, H. N., Lobo, R. A., Allison, M. A.

“…Hormone replacement therapy (HRT) was the standard of care for menopause management until 2002, when perceptions changed following release of the initial…”
Get full text

The role of carotid arterial intima-media thickness in predicting clinical coronary events by HODIS, H. N, MACK, W. J, LABREE, L, SELZER, R. H, LIU, C.-R, LIU, C.-H, AZEN, S. P

“…Carotid arterial intima-media thickness is used as a noninvasive surrogate end point to measure progression of atherosclerosis, but its relation to coronary…”
Get full text

Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis by Hodis, H N

Get full text

Prevention of diseases after menopause by Lobo, R. A., Davis, S. R., De Villiers, T. J., Gompel, A., Henderson, V. W., Hodis, H. N., Lumsden, M. A., Mack, W. J., Shapiro, S., Baber, R. J.

“…Abstract Women may expect to spend more than a third of their lives after menopause. Beginning in the sixth decade, many chronic diseases will begin to emerge,…”
Get full text

Menopausal hormone therapy and coronary heart disease: the roller-coaster history by Nudy, M, Buerger, J, Dreibelbis, S, Jiang, X, Hodis, H N, Schnatz, P F

“…In the USA it is estimated that more than one million women become menopausal each year. Coronary heart disease (CHD) is the leading cause of mortality in…”
Get full text

Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group by Mayer, Kenneth H., Dubé, Michael P., Sprecher, Dennis, Henry, W. Keith, Aberg, Judith A., Torriani, Francesca J., Hodis, Howard N., Schouten, Jeffrey, Levin, Jules, Myers, Gary, Zackin, Robert, Nevin, Thomas, Currier, Judith S.

“…Dyslipidemia is a prevalent condition that affects patients infected with human immunodeficiency virus (HIV) who are receiving antiretroviral therapy. These…”
Get full text

Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials? by Hodis, H. N., Sarrel, P. M.

“…The relationship between menopausal hormone therapy (HT) and breast cancer is complex and further complicated by misinformation, perception, and…”
Get full text

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin by HODIS, H. N, MACK, W. J, AZEN, S. P, ALAUPOVIC, P, POGODA, J. M, LABREE, L, HEMPHILL, L. C, KRAMSCH, D. M, BLANKENHORN, D. H

“…The Monitored Atherosclerosis Regression Study, a randomized, double-blind, placebo-controlled, 2-year trial of lovastatin monotherapy, found that coronary…”
Get full text

Determinants of attained estradiol levels in response to oral estradiol plus progesterone therapy by Sriprasert, I., Hodis, H. N., Bernick, B., Mirkin, S., Mack, W. J.

“…Among postmenopausal women taking hormone therapy (HT), the estradiol (E2) dose and E2 levels were differentially associated with change in metabolic measures…”
Get full text

The association of smoking and subclinical atherosclerosis in Type 2 diabetes: modification by duration of diabetes by Karim, R., Buchanan, T. A., Hodis, H. N., Li, Y., Mack, W. J.

“…Background  Diabetes is a relatively common disease in the United States, and cardiovascular disease is the major cause of morbidity and mortality among…”
Get full text

The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective by Hodis, H. N., Collins, P., Mack, W. J., Schierbeck, L. Lind

“…ABSTRACT Over the past decade, two informative events in primary prevention of coronary heart disease (CHD) have occurred for women's health. The first…”
Get full text

Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima-media thickness by Markus, RA, Mack, WJ, Azen, SP, Hodis, HN

“…The Monitored Atherosclerosis Regression Study (MARS) was a randomized, double-blind, placebo-controlled angiographic trial of lipid-lowering therapy in…”
Get full text

Triglyceride-rich lipoproteins and progression of atherosclerosis by HODIS, H. N, MACK, W. J

“…To present data from the Cholesterol Lowering Atherosclerosis Study (CLAS) and the Monitored Atherosclerosis Regression Study (MARS) demonstrating the…”
Get full text

Association of oral estradiol dose/levels with coagulation measures in early/late postmenopausal women by Sriprasert, I., Hodis, H. N., Bernick, B., Mirkin, S., Mack, W. J.

“…Objective: This study evaluated associations of estradiol (E2) dose and serum E2 levels with coagulation/anti-coagulation measures in early (<6 years) compared…”
Get full text

Reduction in carotid arterial wall thickness using lovastatin and dietary therapy : A randomized, controlled clinical trial by HODIS, H. N, MACK, W. J, LABREE, L, SELZER, R. H, LIU, C.-R, LIU, C.-H, ALAUPOVIC, P, KWONG-FU, H, AZEN, S. P

“…To assess the effects of lipid-lowering therapy on the progression of early, preintrusive carotid arterial atherosclerosis. Randomized, double-blind,…”
Get full text

Coronary angiographic changes with lovastatin therapy : the monitored atherosclerosis regression study (MARS) by BLANDKENHORN, D. H, AZEN, S. P, ALAUPOVIC, P, HIRSCH, L. J, KRAMSCH, D. M, MACK, W. J, CASHIN-HEMPHILL, L, HODIS, H. N, DEBOER, L. W. V, MAHRER, P. R, MASTELLER, M. J, VAILAS, L. I

“…To assess the effects of lipid-lowering therapy with lovastatin on coronary angiographic findings in patients with coronary artery disease and to compare the…”
Get full text